Citations

Clear

3314 citation(s) found for "Do, Alexander".

Harnessing the "Golden Hour" in Critically Ill Patients: A Pilot Trial of a Checklist-based Optimization of Intensive Care Unit Admissions
Parton, T., Zambrano, Claudia Castillo , Montgomery, A., Chalmers, Sarah , Tekin, Aysun , Kantas, D., Dong, Yue , Niven, Alexander S. , Gajic, Ognjen

Mayo Clinic

B35. CRITICAL CARE QUALITY IMPROVEMENT, TRAINING, AND HEALTH SERVICES RESEARCH | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A3358-A3358

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3358 Get It

IRF1 Is a Major Regulatory Transcription Factor for Immune Responses in Eosinophils
Nazaroff, Christopher D. , Krupnick, Alexander S. , Jacobsen, Elizabeth A. , Schutte, A., Kienzl, Melanie

Mayo Clinic

C35. INNOVATIVE BIOMARKERS TO IDENTIFY ALLERGIC INFLAMMATION | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5403-A5403

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5403 Get It

Comparative Assessment of CO 2 Emissions in Various Delivery Methods of the Certain Critical Care Education Program
Zambrano, Claudia Castillo , Gajić, Ognjen, Wang, B.Y., Niven, Alexander S. , Gajic, Ognjen , Dong, Yue

Mayo Clinic

A39. EDUCATING THE EDUCATORS: ADVANCES IN CRITICAL CARE MEDICAL EDUCATION | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1509-A1509

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1509 Get It

Aerosol Generation Using Different Delivery Methods During Simulated Bronchodilator Challenge Testing in the Pulmonary Function Laboratory
Gmehlin, C.G., Sajgalik, Pavol , Hainy, M., Chul-Ho, K., Johnson, Bruce D. , Allison, Thomas G. , Chul-Ho, K., Lim, Kaiser G. , Niven, Alexander S.

Mayo Clinic

A75. REVISITING CURRENT METHODS IN PULMONARY FUNCTION TESTING | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A2626-A2626

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2626 Get It

Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy
Malik, Awais , Saraswati, Ushasi , Miranda, William R. , Covington, Megan K. , Scott, Christopher G. , Lee, Alexander T. , Arruda‐Olson, Adelaide M. , Geske, Jeffrey B. , Klarich, Kyle W. , Anand, Vidhu , Malik, Awais A, Covington, Megan , Lee, Alex T , Arruda-Olson, Adelaide M , Scott, Christopher , Geske, Jeffrey B , Saraswati, Ushasi

Mayo Clinic

Journal of the American Heart Association | April 30, 2024 | Volume: 13 | Issue: 9 | Pages: No page available

10.1161/jaha.123.032520 | PMID 38686858 Get It

Background Symptomatic limitations in apical hypertrophic cardiomyopathy may occur because of diastolic dysfunction with resultant elevated left ventricular filling pressures, cardiac output limitation to exercise, pulmonary hypertension (PH), valvular abnormalities, and/or arrhythmias. In this study, the authors aimed to describe invasive cardiac hemodynamics in a cohort of patients with apical hypertrophic cardiomyopathy. Methods and Results Patients presenting to a comprehensive hypertrophic cardiomyopathy center with apical hypertrophic cardiomyopathy were identified (n=542) and those who underwent invasive hemodynamic catheterization (n=47) were included in the study. Of these, 10 were excluded due to postmyectomy status or incomplete hemodynamic data. The mean age was 56±18 years, 16 (43%) were women, and ejection fraction was preserved (≥50%) in 32 (91%) patients. The most common indication for catheterization was dyspnea (48%) followed by suspected PH (13%), and preheart transplant evaluation (10%). Elevated left ventricular filling pressures at rest or exercise were present in 32 (86%) patients. PH was present in 30 (81%) patients, with 6 (20%) also having right‐sided heart failure. Cardiac index was available in 25 (86%) patients with elevated resting filling pressures. Of these, 19 (76%) had reduced cardiac index and all 6 with right‐sided heart failure had reduced cardiac index. Resting hemodynamics were normal in 8 of 37 (22%) patients, with 5 during exercise; 3 of 5 (60%) patients had exercise‐induced elevation in left ventricular filling pressures. Conclusions In patients with apical hypertrophic cardiomyopathy undergoing invasive hemodynamic cardiac catheterization, 86% had elevated left ventricular filling pressures at rest or with exercise, 81% had PH, and 20% of those with PH had concomitant right‐sided heart failure.
α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden
Xiong, Chengjie , Quadalti, Corinne , Rossi, Marcello , Vöglein, Jonathan , Bernhardt, Alexander , Perrin, Richard J. , Preische, Oliver, Hofmann, Anna, Cairns, Nigel J. , Franklin, Erin , Chrem, Patricio, Berman, Sarah , Chhatwal, Jasmeer P. , Daniels, Alisha , Day, Gregory S. , Ryan, Natalie S. , Goate, Alison , Gordon, Brian A. , Huey, Edward D. , Masters, Colin L. , Morris, John C. , Noble, James M. , Roh, Jee Hoon , Frosch, Matthew P. , Sánchez‐Valle, Raquel , Supnet, Charlene , Network, Dominantly Inherited Alzheimer, Xiong, Chengjie , Parchi, Piero , Gordon, Brian A , Sánchez-Valle, Raquel , Day, Gregory S , Masters, Colin L , Vöglein, Jonathan , Morris, John C , Roh, Jee Hoon , Goate, Alison M , Supnet-Bell, Charlene , Berman, Sarah , Noble, James M , Baiardi, Simone , Iranzo, Alex , Jucker, Mathias , Höglinger, Günter U. , Cruchaga, Carlos , Ibanez, Laura , Karch, Celeste M. , Lee, Jae‐Hong , Llibre‐Guerra, Jorge J. , Lopera, Francisco Javier , Renton, Alan , Keene, C. Dirk , McLean, Catriona , Schofield, Peter R. , Xiong, Chengjie , Giese, Armin , Hansson, Oskar , Bateman, Randall J. , McDade, Eric , Network, Dominantly Inherited Alzheimer

Mayo Clinic

Alzheimer's & Dementia | April 26, 2024 | Volume: 20 | Issue: 6 | Pages: 4351-4365

10.1002/alz.13818 | PMID 38666355 Get It

AbstractINTRODUCTIONAmyloid beta and tau pathology are the hallmarks of sporadic Alzheimer's disease (AD) and autosomal dominant AD (ADAD). However, Lewy body pathology (LBP) is found in ≈ 50% of AD and ADAD brains.METHODSUsing an α‐synuclein seed amplification assay (SAA) in cerebrospinal fluid (CSF) from asymptomatic (n = 26) and symptomatic (n = 27) ADAD mutation carriers, including 12 with known neuropathology, we investigated the timing of occurrence and prevalence of SAA positive reactivity in ADAD in vivo.RESULTSNo asymptomatic participant and only 11% (3/27) of the symptomatic patients tested SAA positive. Neuropathology revealed LBP in 10/12 cases, primarily affecting the amygdala or the olfactory areas. In the latter group, only the individual with diffuse LBP reaching the neocortex showed α‐synuclein seeding activity in CSF in vivo.DISCUSSIONResults suggest that in ADAD LBP occurs later than AD pathology and often as amygdala‐ or olfactory‐predominant LBP, for which CSF α‐synuclein SAA has low sensitivity.Highlights Cerebrospinal fluid (CSF) real‐time quaking‐induced conversion (RT‐QuIC) detects misfolded α‐synuclein in ≈ 10% of symptomatic autosomal dominant Alzheimer's disease (ADAD) patients. CSF RT‐QuIC does not detect α‐synuclein seeding activity in asymptomatic mutation carriers. Lewy body pathology (LBP) in ADAD mainly occurs as olfactory only or amygdala‐predominant variants. LBP develops late in the disease course in ADAD. CSF α‐synuclein RT‐QuIC has low sensitivity for focal, low‐burden LBP.
The role of vascularized bone grafting for scaphoid nonunions in adolescents
Israel, Jacqueline S. , Pulos, Nicholas , Pulos, Nicholas , Bishop, Allen T. , Shin, Alexander Y.

Mayo Clinic

Journal of Hand Surgery (European Volume) | April 25, 2024 | Volume: 49 | Issue: 9 | Pages: 1157-1159

10.1177/17531934241247279 | PMID 38663874 Get It

A total of 26 adolescent patients were treated for scaphoid nonunion with a vascularized bone graft from either the medial femoral condyle or dorsal distal radius. There was an 85% union incidence, improved carpal alignment and a low incidence of complications.
Description and evaluation of a self-operated waist measurement device
Song, Yilin , Philbrick, Kenneth A. , Weston, Alexander D. , Potretzke, Theodora A. , Lytle, Kelli A. , Jensen, Teresa B. , Jensen, Michael D.

Mayo Clinic

BMJ Innovations | April 25, 2024 | Volume: 10 | Issue: 3 | Pages: 88-95

10.1136/bmjinnov-2023-001162 Get It

Background National guidelines recommend that waist circumference (WC) be measured in patients with a body mass index (BMI) 27–35 kg/m2. Unfortunately, perhaps due to logistical reasons, WC is seldom measured in clinical settings. Herein, we describe the performance of a self-operated waist measurement device (SOWMD) as a potential means to overcome barriers to measuring WC. Materials and methods Ten volunteers underwent WC measures by professionals and SOWMD on 5 separate days to assess the reproducibility and accuracy. We then compared SOWMD measures with CT-derived fat content by recruiting 81 patients scheduled for a diagnostic abdominal CT scan. Results There was no difference between professionally measured and SOWMD-measured WC; the intraindividual coefficient of variation over the 5 days was between 0.4% and 2.2%. The WC measured manually, by SOWMD and CT scan were highly correlated (r=0.90–0.92, all p<0.001). The minimal WC measured by SOWMD was a better predictor (r=0.81 for all patients, r=0.87 for men, both p<0.001) of CT-measured visceral adipose tissue volume than other approaches. The minimal WC measured by SOWMD was correlated with fasting plasma glucose (r=0.40, p<0.05), triglyceride (r=0.41, p<0.01) and high-density cholesterol (r=−0.49, p<0.001) concentrations. Conclusion SOWMD is a reproducible, accurate and convenient way to measure WC that can provide added value for health care providers when combined with BMI information.
Abstract 16833: Long-Term Outcomes and Complications of Anticoagulant Therapy for Bioprosthetic Valve Thrombosis in a Large Matched-Cohort Study
Petrescu, Ioana, Connolly, Heidi M. , Egbe, Alexander C. , Ionescu, Filip , Nkomo, Vuyisile T. , Pellikka, Patricia A. , Pislaru, Cristina , Pislaru, Sorin V.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 138 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.138.suppl_1.16833 Get It

Introduction: Bioprosthetic valve thrombosis (BPVT) is a well-recognized cause of prosthetic dysfunction. Anticoagulation restores prosthetic valve gradients, but long term outcomes and complications from therapy are unknown. Objectives: To define the complications and long-term outcomes of anticoagulant therapy for BPVT. Methods: Retrospective matched cohort study of patients treated with warfarin for presumed BPVT at a single center from 1999 to 2016. Controls with normal bioprostheses by echocardiography were matched 2:1 for age at implantation, gender, prosthetic valve position, and type of prosthesis (porcine / pericardial). Results: A total of 83 presumed BPVT patients (40 aortic, 21 mitral, 18 tricuspid, and 4 pulmonary) and 166 controls were included. Age at BPVT diagnosis was 60±19 yrs (41±41 months post implantation); 45 (54%) were male. Transvalvular gradients returned to baseline in 63 (76%) of the patients, after 5±4 months of warfarin; 60 (72%) patients were maintained on warfarin indefinitely. Recurrent BPVT was seen in 13 (16%) patients, 33±31 months after initial therapy. When compared to controls, warfarin-treated BPVT patients had similar incidence of stroke [4(5%) vs 5 (3%), p=0.49], peripheral embolic events [4(5%) vs 10 (6%), p=0.78)], and death [12 (14%) vs 28 (17%), p= 0.72] (Figure, left panel), but more bleeding requiring transfusion [18 (22%) vs 3 (2%), p<0.0001]. Presumed BPVT patients more often required surgical or percutaneous valve re-replacement (Figure, center panel); this difference persisted even when comparing only patients with confirmed BPVT (those who responded to anticoagulant therapy) vs. their matched controls (Figure, right panel). Conclusion: Warfarin anticoagulation for presumed BPVT is successful in the majority of patients, without increase in stroke, peripheral embolism or death, but at the cost of excess bleeding. Recurrent BPVT occured in 16% of patients. Importantly, patients with BPVT required more often valve re-replacement. This finding suggests that anticoagulant therapy does not fully restore prosthetic valve durability, and that BPVT patients should be closely monitored.
Abstract 12705: Mechanisms of Decreased Exercise Capacity with Sleep Disordered Breathing in Hypertrophic Cardiomyopathy
Konečný, Tomáš , Brady, Peter, Ludka, Ondřej , Placek, Alexander, Orban, Marek , Kára, Tomáš, Tajik, Jamil, Allison, Thomas, Ommen, Steve R. , Brady, Peter, Gersh, Bernard J. , Somers, Virend K.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 126 | Issue: suppl_21 | Pages: No page available

10.1161/circ.126.suppl_21.a505 Get It

Tomas Konecny, 2012 Finalist and Presenting Author